The bill would amend the Public Health Service Act, remove the statute of limitations for certain claims and end COVID-19 vaccines' classification as "countermeasures" under the Public Readiness and Emergency Preparedness Act (PREP Act).The PREP Act, invoked in 2020 during the COVID-19 emergency, provides broad immunity from liability to governments, manufacturers, distributors and health professionals, except in cases involving proven "willful misconduct."As of Jan. 2, the federal Vaccine Adverse Event Reporting System (VAERS) has logged 1,673,223 reports of adverse events following COVID-19 vaccination, including deaths, hospitalizations, heart attacks and myocarditis cases;Centers for Disease Control and Prevention(CDC) researchers have noted a high verification rate for reported myocarditis.Studies from Harvard Medical School and other researchers suggest adverse events may be underreported in VAERS, while international research published in Vaccine identified elevated risks of certain conditions following mRNA COVID-19 vaccination, findings that authors say warrant further investigation.
The PREP Act, invoked in 2020 during the COVID-19 emergency, provides broad immunity from liability to governments, manufacturers, distributors and health professionals, except in cases involving proven "willful misconduct."As of Jan. 2, the federal Vaccine Adverse Event Reporting System (VAERS) has logged 1,673,223 reports of adverse events following COVID-19 vaccination, including deaths, hospitalizations, heart attacks and myocarditis cases;Centers for Disease Control and Prevention(CDC) researchers have noted a high verification rate for reported myocarditis.Studies from Harvard Medical School and other researchers suggest adverse events may be underreported in VAERS, while international research published in Vaccine identified elevated risks of certain conditions following mRNA COVID-19 vaccination, findings that authors say warrant further investigation.
As of Jan. 2, the federal Vaccine Adverse Event Reporting System (VAERS) has logged 1,673,223 reports of adverse events following COVID-19 vaccination, including deaths, hospitalizations, heart attacks and myocarditis cases;Centers for Disease Control and Prevention(CDC) researchers have noted a high verification rate for reported myocarditis.Studies from Harvard Medical School and other researchers suggest adverse events may be underreported in VAERS, while international research published in Vaccine identified elevated risks of certain conditions following mRNA COVID-19 vaccination, findings that authors say warrant further investigation.
Studies from Harvard Medical School and other researchers suggest adverse events may be underreported in VAERS, while international research published in Vaccine identified elevated risks of certain conditions following mRNA COVID-19 vaccination, findings that authors say warrant further investigation.
S.3853 would also remove the statute of limitations for individuals seeking compensation under the previous law and end the classification of COVID-19 vaccines as "countermeasures" under thePublic Readiness and Emergency Preparedness Act, commonly known as the PREP Act. The PREP Act provides liability protections to manufacturers and others involved in the development and distribution of designated medical countermeasures during public health emergencies.If enacted, the legislation would eliminate the general immunity vaccine manufacturers enjoy under the 1986 law and allow individuals to pursue civil actions regardless of whether they have filed a petition with the federal compensation program.This shift, according toBrightU.AI's Enoch, could have significant implications for public health, as the threat of litigation might lead to increased scrutiny and accountability in the development and distribution of vaccines.
S.3853 would also remove the statute of limitations for individuals seeking compensation under the previous law and end the classification of COVID-19 vaccines as "countermeasures" under thePublic Readiness and Emergency Preparedness Act, commonly known as the PREP Act. The PREP Act provides liability protections to manufacturers and others involved in the development and distribution of designated medical countermeasures during public health emergencies.
If enacted, the legislation would eliminate the general immunity vaccine manufacturers enjoy under the 1986 law and allow individuals to pursue civil actions regardless of whether they have filed a petition with the federal compensation program.This shift, according toBrightU.AI's Enoch, could have significant implications for public health, as the threat of litigation might lead to increased scrutiny and accountability in the development and distribution of vaccines.
If enacted, the legislation would eliminate the general immunity vaccine manufacturers enjoy under the 1986 law and allow individuals to pursue civil actions regardless of whether they have filed a petition with the federal compensation program.
This shift, according toBrightU.AI's Enoch, could have significant implications for public health, as the threat of litigation might lead to increased scrutiny and accountability in the development and distribution of vaccines.
This shift, according toBrightU.AI's Enoch, could have significant implications for public health, as the threat of litigation might lead to increased scrutiny and accountability in the development and distribution of vaccines.
Source: NaturalNews.com
